CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER <sup>1%–20%</sup> ) early-stage breast cancer patients helps guide treatment decisions
CAB-based risk stratification of ER<sup>1%-20%</sup> patients is significant and would add value in treatment decisions for additional targeted treatments to HR patients.
Authors
- Susmita Ghosh (ORCID: https://orcid.org/0000-0001-6591-9147)
- Badada Ananthamurthy Savitha
- Manjiri M. Bakre (ORCID: https://orcid.org/0000-0003-1160-8102)
- Naveen Krishnamoorthy (ORCID: https://orcid.org/0000-0002-2627-2501)
- Payal Shrivastava
- Manvi Sunder
- Deepti K. Shivashimpi
- Tejal Deepak Durgekar
Publication Details
- Journal
- Therapeutic Advances in Medical Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17588359251342218
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.94